7th European Conference on Schizophrenia Research

20 SCIENTIFIC PROGRAMME | Friday, 27 September 2019 S-10 SYMPOSIA 08:30–10:00 Plenary Pathobiology, measurement and treatment of motor signs in psychosis Chairs: S. Walther, Bern, Switzerland P. van Harten, Amersfoort, The Netherlands S-10-001 Motor symptoms in schizophrenia are related to disease pathophysiology rather than anti- psychotic treatment D. Hirjak, Mannheim, Germany S-10-002 Implicit encoding of movement probability and corticospinal excitability in schizophrenia L. Dupin, Paris, France S-10-003 Treatment options of psychomotor symptoms– a case for neurostimulation? S. Walther, Bern, Switzerland D. Alexaki, L. Schäppi S-10-004 Smart devices: An aid for the clinician to mea- sure motor signs P. van Harten, Amersfoort, The Netherlands S-11 SYMPOSIA 08:30–10:00 Harvard Schizophrenia and cancer. The role of microRNAs Chairs: E. Rizos, Athens, Greece V. Zoumpourlis, Athens, Germany S-11-001 The low cancer risk in patients suffering from schizophrenic spectrum disorder. The possible role of microRNAs. Future medication strategies E. Rizos, Athens, Greece V. Zoumpourlis, N. Siafakas, E. Katsantoni S-11-002 MicroRNAs in central nervous system disorders N. Siafakas, Athens, Greece S-11-003 Identification of miRNAs with potential thera- peutic value in the treatment of various cancer types V. Zoumpourlis, Athens, Germany S-11-004 STAT target genes networks: Towards biomark- ers discovery E. Katsantoni, Athens, Greece